Table 2 The enhancement patterns of combined hepatocellular-cholangiocarcinoma on CEUS in 45 patients
Enhancement appearance | Number % |
|---|---|
Arterial phase | |
Peripheral hyperenhancement | 9 (20.0) |
Heterogeneous hyperenhancemen | 22 (48.9) |
Homogeneous hyperenhancement | 13 (28.9) |
Hypoenhancement | 1 (0.2) |
Isoenhancement | 0 (0) |
Portal phase | |
Peripheral hyperenhancement | |
Heterogeneous hyperenhancement | 1 (0.2) |
Homogeneous hyperenhancement | 0 (0) |
Slight hypoenhancement | 17 (37.8) |
Marked hypoenhancement | 25 (55.6) |
Isoenhancement | 2 (0.4) |
Delayed phase | |
Peripheral hyperenhancement | |
Heterogeneous hyperenhancement | 1 (0.2) |
Homogeneous hyperenhancement | |
Slight hypoenhancement | 8 (17.8) |
Marked hypoenhancement | 35 (77.8) |
Isoenhancement | 1 (0.2) |
Emergence of-washout | |
< 60 seconds | 28 (62.2) |
60–120 seconds | 13 (28.9) |
> 120 seconds | 2 (4.4) |
No washout | 2 (4.4) |